Invention Grant
- Patent Title: Compositions comprising N. meningitidis proteins
-
Application No.: US15534438Application Date: 2015-12-08
-
Publication No.: US10232029B2Publication Date: 2019-03-19
- Inventor: Genevieve Renauld-Mongenie , Bachra Rokbi , Noelle Mistretta
- Applicant: SANOFI PASTEUR
- Applicant Address: FR Lyons
- Assignee: Sanofi Pasteur
- Current Assignee: Sanofi Pasteur
- Current Assignee Address: FR Lyons
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP14306978 20141209
- International Application: PCT/EP2015/079021 WO 20151208
- International Announcement: WO2016/091902 WO 20160616
- Main IPC: A61K39/095
- IPC: A61K39/095 ; C07K14/22 ; A61K39/00
Abstract:
The invention relates to immunogenic compositions comprising at least two Neisseria meningitidis (Nm) protein antigens selected from the group consisting of a trypsin-like serine protease auto-transporter antigen such as IgAI P, App or AusI antigen, a NalP antigen and a TbpB antigen. Preferably, the composition of the invention comprises (i) the trypsin-like serine protease auto-transporter antigen and (ii) the NalP antigen and/or TbpB antigen.
Public/Granted literature
- US20180125959A1 COMPOSITIONS COMPRISING N. MENINGITIDIS PROTEINS Public/Granted day:2018-05-10
Information query
